Quote:
As the result of an ongoing safety review, FDA has notified the manufacturers of licensed botulinum toxin products of the need to strengthen warnings in product labeling, and add a boxed warning, regarding the risk of adverse events when the effects of the toxin spread beyond the site where it was injected.............
|
to read the full alert please go to
http://www.fda.gov/cder/drug/early_c...xins200904.htm